Literature DB >> 1679759

Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.

Y Takeda1, M J Escribano.   

Abstract

The effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines, BxPC-3 and SOJ-6, were studied. The BxPC-3 cell line (American Type Culture Collection no. CRL 1687) was derived from a moderately differentiated pancreatic adenocarcinoma. The SOJ-6 cell line is a subclone of SOJ that was initiated from ascites of a well-differentiated pancreatic adenocarcinoma. Both cell lines express fetoacinar pancreatic antigen, an antigen that might be associated with early transformation stages. However, these lines have different proliferation and tumoral powers. SOJ-6 cells showed an almost twofold higher division rate over BxPC-3 cells when cultured in RPMI-1640 medium containing 10% fetal bovine serum. The tumorigenic degree of SOJ-6 cells, as assessed by tumor growth in nude mice, was about three times greater than that of BxPC-3. The in vitro growth of BxPC-3 cells was significantly promoted by insulin, and was slightly inhibited by somatostatin, whereas the growth of SOJ-6 cells was not influenced by these hormones. Using a clonogenic assay in soft agar, the average ratio of colony numbers formed by SOJ-6 and BxPC-3 was about 10/1, indicating a good correlation between the colony formation and tumorigenic degree in vivo. In this test, the number of colonies formed by BxPC-3 cells was increased about twofold in insulin-supplemented medium. On the other hand, somatostatin inhibited the colony formation by a factor of four to six. However, no hormonal modulation of the colony formation of SOJ-6 cells was observed. Our data show that pancreatic cancer cell lines respond differently to pancreatic hormones, and suggest that this may be correlated to a tumour stage or a tumour type.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679759     DOI: 10.1007/bf01612760

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Growth factors for mammalian cells in culture.

Authors:  I LIEBERMAN; P OVE
Journal:  J Biol Chem       Date:  1959-10       Impact factor: 5.157

2.  Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas.

Authors:  D Gonzalez-Barcena; N E Rangel-Garcia; P L Perez-Sanchez; C Gutierrez-Damperio; F Garcia-Carrasco; A M Comaru-Schally; A V Schally
Journal:  Lancet       Date:  1986-07-19       Impact factor: 79.321

3.  [Establishment and characterization of human pancreatic adenocarcinoma cell line SOJ producing carcinoembryonic antigen and carbohydrate antigen 19-9].

Authors:  Y Fujii; M Sekiguchi; Y Shiroko; H Shimizu; I Sugawara; K Hasumi; M Eriguchi; T Ikeuchi; H Uchida
Journal:  Hum Cell       Date:  1990-03       Impact factor: 4.174

4.  Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice.

Authors:  G J Poston; C M Townsend; S Rajaraman; J C Thompson; P Singh
Journal:  Pancreas       Date:  1990-03       Impact factor: 3.327

5.  Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.

Authors:  A Zalatnai; A V Schally
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

6.  Proliferation of immunocytochemically identified islet beta cells in culture: effect of growth factors, hormones, and nutrients.

Authors:  H Popiela; W Moore
Journal:  Pancreas       Date:  1989       Impact factor: 3.327

7.  The somatostatin receptor on isolated pancreatic acinar cell plasma membranes. Identification of subunit structure and direct regulation by cholecystokinin.

Authors:  C Sakamoto; I D Goldfine; J A Williams
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

8.  Ultrastructural analysis of pancreatic carcinogenesis. V. Changes in differentiation of acinar cells during chronic treatment with N-nitrosobis(2-hydroxypropyl)amine.

Authors:  B Flaks; M A Moore; A Flaks
Journal:  Carcinogenesis       Date:  1982       Impact factor: 4.944

9.  Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat.

Authors:  B D Roebuck; K J Baumgartner; C D Thron
Journal:  Lab Invest       Date:  1984-02       Impact factor: 5.662

10.  Evolution of the expression of fetal acinar antigens during carcinogenesis of the pancreas in hamsters: individual follow-up by open biopsy.

Authors:  M Eriguchi; A Carré-Llopis; S Orbach-Arbouys; J Escribano
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

View more
  12 in total

1.  Radioimmunolocalization of the monoclonal antibody J28 in early transformation stages in N-nitrosobis(2-hydroxypropyl)amine-induced pancreatic tumors in the Syrian golden hamster.

Authors:  Y Takeda; F Miralles; N Daher; M J Escribano
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study.

Authors:  A Zalatnai
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.

Authors:  E Kouroumalis; P Skordilis; K Thermos; A Vasilaki; J Moschandrea; O N Manousos
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

Review 4.  Somatostatin, somatostatin receptors, and pancreatic cancer.

Authors:  Min Li; William E Fisher; Hee Joon Kim; Xiaoping Wang; Charles F Brunicardi; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 5.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

Review 6.  Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.

Authors:  W E Fisher; P Muscarella; L G Boros; W J Schirmer
Journal:  Int J Pancreatol       Date:  1998-12

7.  Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts.

Authors:  S C Larsson; J Permert; N Håkansson; I Näslund; L Bergkvist; A Wolk
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

8.  Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria.

Authors:  K Rapp; J Schroeder; J Klenk; S Stoehr; H Ulmer; H Concin; G Diem; W Oberaigner; S K Weiland
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

Review 9.  The relationship between diabetes and pancreatic cancer.

Authors:  Feng Wang; Margery Herrington; Jörgen Larsson; Johan Permert
Journal:  Mol Cancer       Date:  2003-01-06       Impact factor: 27.401

10.  Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor.

Authors:  Iván A González; Liang-I Kang; Gregory A Williams; Jingxia Liu; David G DeNardo; William G Hawkins; Deyali Chatterjee
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.